torasemide Tablets 10mg

This pharmaceutical group is experiencing rapid growth, increasing its turnover from Rs. 1.5 crores in 2006 to Rs. 12 crores by 2009-2010 and aiming for Rs. 50 crores by 2015. While specific product details are not provided, the company operates across diverse therapeutic areas with a focus on both prescription medications and over-the-counter drugs. They highlight their management team's vision and dynamism, suggesting strong leadership driving their expansion within India.